© 2021 KOMAND Consulting
Other
Chemo Nausea
Epilepsy
Spasticity
Multiple Sclerosis
Pain
1.4%
2.4%
2.5%
3.7%
10.0%
80.0%
DENMARK
Population: 5,827,463
GDP/Capita: USD$51,643
Wholesale Medical Flower Price/Gram: €15 (Granulated)
Pharmacy purchase price from licenced distributor
Current Med/Rec Usage (15-64yrs): 6.4% (2017 Prevalence)
Patient Count Q2-2021
1,527
TTM Prescriptions Q2-2021
13,406
Patient Count Q2-2020
1,540
Prescriptions 2020
12,615
Category Product Intermediary Product Manufacturer
Pilot Programme Bediol flos, flower preparation CannGros ApS Bedrocan B.V.
Bedrocan flos, flower preparation CannGros ApS Bedrocan B.V.
Bedica flos, flower preparation CannGros ApS Bedrocan B.V.
Sedamen, Soft Capsules Aurora Nordic Cannabis A/S MedReleaf Corp
Magistral preparation THC oral drops Glostrup Pharmacy Glostrup Pharmacy
THC capsules
THC/CBD capsules
CBD oral drops
CBD capsules
Market Authorized Sativex, oral cavity spray 2care4 GW Pharmaceuticals
Almirall
Orifarm
Epidyolex, oral solution n/a GW Pharmaceuticals
Compassionate Permit Marinol, capsules Direct Import (special permit) Unimed Pharmaceuticals
Nabilone/Cesamet, capsules Valeant Pharmaceuticals
Medical Cannabis Consumption in Denmark
Trailing 12-Month (kg of active substance)
b
4.1 kg
1.9 kg
2.6 kg
8.4 kg
0.7 kg
18.6 kg
Granulated Flower
Sedamen Capsules
Magistral Prepared
Drops/Capsules
Sativex/Epidiolex/
Marinol
Patient/Prescription Count
c
Danish Conditions/Symptoms
Percentage by Patient Prescriptions
Source: Sundhedsdatastyrelsen quarterly reports
Other:
Dystonia, Connective tissue disease,
Anorexia, Stubborn Bladder Syndrome,
Brain Cancer, Trigeminal neuralgia,
Anxiety, Inflammation
Sources : European Monitoring Centre for Drugs & Drug Addiction (EMCDDA)
Statistics Denmark, medicinpriser.dk, IMF
Medicinal Cannabis Products Approved in Denmark
Sources : procon.org, Sundhedsdatastyrelsen quarterly reports, MEDICINPRISER.DK
STATUS
Denmark has an open-ended 4-year pilot program
Doctors are guided to prescribe cannabis products to patients
who have failed to respond to traditional therapies
The information and evidence collected during the trial will
form the basis of more permanent legislation
NEWS
Danish Minister submits bill to continue Pilot med cannabis programme
QNTM Labs Secures €3.5m in Funding
Aurora says its Danish cannabis has reached German pharmacies
Status Quo & Recent News
PatientsProducts
Product
THC/CBD
per gram
Package
Size
Package
cost (Retail)
Bedrocan flos, Granulated Flower
220mg / 0 5g
€93
Bediol flos, Granulated Flower
63mg/80mg 5g
€105
Bedica flos, Granulated Flower
140mg / 0 5g
€105
Sedamen Soft Capsules
80-120mg/ 0
100 Capsules
5g
€200
Sativex, oral cavity spray
27mg/25mg 3 x 10ml
€548
Epidyolex, oral solution
100 mg/ml 100ml
€1,712
Dronabinol (Marinol), capsules
Max 1mg / 0
Capsule
0.25/0.5/1mg
n/a
Nabilone (Canemes), capsules
Max 10mg/0
28 Capsules
2.5/5/10mg
n/a
List of Approved Products - Laegemiddelstyrelsen
a
a
Laegemiddelstyrelsen = Danish Medicines Agency
THC/CBD per gram is the “Active Substance” amount (the isolated pure THC &
CBD per gram)
b
THC/CBD per gram is the “Active Substance” amount (the isolated THC & CBD
per gram)
Back to Europe
Product Channels
Medical Cannabis Prescriptions (per Quarter)
d
d
Combination of Pilot Program + Magistral Preparations + Pharma Drugs
Pilot Program : Products covered by the trial scheme
Magistral : Pharmacy prepared drugs (containing cannabis), prepared for
a specific patient according to the doctor's instructions
The magistral authorisation is separate from the pilot program
Danish Pilot Program
Guidance on physicians’ Patient Treatment
e
1. Chronic pain conditions
2. Nervous pain (neurogenic or neuropathic pain)
3. Generalized pain in the moving apparatus
4. Pain inflammatory and degenerative joint diseases
5. Osteoarthritis (osteoarthritis)
6. Pain in osteoporosis
7. Cancer Pain
8. Multiple Sclerosis (MS)
9. Spinal cord injury (paraplegia)
10. Nausea and vomiting after chemotherapy
e
The Danish Medicines Agency renders these conditions relevant to treat
with medical cannabis, but it is not obligatory. These 10 conditions serve
as the guidelines for the trial
Active Substance
TTM
36.2kg
Q2-2021
c
The Patient Count is the number of unique users during the reported
quarter
Prescription Count is total prescriptions written per Trailing 12-month period
Q2-2021
Q1-2021
Q4-2020
Q3-2020
Q2-2020
Q1-2020
Q4-2019
Q3-2019
3262
3446
3571
3127
2974
2943
2770
2777
Last Updated – Oct 2021
Laegemiddelstyrelsen - Danish Medicines Agency
Cannabis specific dept issues cultivation and handling permits,
manufacturing permits and permitted cannabis products
The European Medicines Agency
Compliance guidelines for EU GMP, EU GDP & EU GACP,
inspection procedures and forms agreed by all EU Member States
Sundhed - Public Health System
For doctors: Approved medical indications, cannabis preparations
and cannabis-based medicine preparations
Regulatory Agencies
Cannabis
Pharma
44.5kg
Dried Flower
Medical Cannabis Sales in Denmark
Trailing 12-Month (€)
Granulated Flower
Sedamen Capsules
Magistral Prepared
Drops/Capsules
Sales TTM
€8.76m
Q2-2021
Pure
CBD
Pure
THC
THC/CBD
€0.6m
€0.6m
€2.7m
€0.9m
€0.3m
€3.7m
Pure
CBD
Pure
THC
THC/CBD
Source: Sundhedsdatastyrelsen quarterly reports
Sativex/Epidiolex/
Marinol
Pharma
Pharma